Clinical Trials Logo

Clopidogrel Resistance clinical trials

View clinical trials related to Clopidogrel Resistance.

Filter by:
  • None
  • Page 1

NCT ID: NCT04027712 Active, not recruiting - Diabetes Clinical Trials

Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD

Start date: January 1, 2014
Phase:
Study type: Observational

Increased circulating b-amyloid and decreased Mitochondrial-derived peptide (MOTS-c), a peptide improving tissue insulin sensitivity, are reported in diabetes. The investigators plan to investigate the association of both biofactors with high on-clopidogrel platelet reactivity and cardiovascular mortality in type 2 diabetic patients with Coronary artery disease

NCT ID: NCT02008123 Withdrawn - Clinical trials for Secondary Stroke Prevention

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Start date: August 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether adding primidone will improve the metabolism of clopidogrel thereby increasing metabolite levels within the blood stream and platelet response to clopidogrel in patients who were previously found to lack adequate response to clopidogrel. This information could help overcome clopidogrel resistance in patients who are at risk for stroke or transient ischemic attack (TIA).